Johnson Wendy S. 4
4 · AmpliPhi Biosciences Corp · Filed Sep 11, 2017
Insider Transaction Report
Form 4
Johnson Wendy S.
DirectorInterim Chief Operating Office
Transactions
- Award
Stock Option (Right to Buy)
2017-09-07+10,900→ 10,900 totalExercise: $0.91From: 2018-09-07Exp: 2027-09-06→ Common Stock (10,900 underlying)